WAKS; Tova

Patent Applications and Registrations

Patent applications and USPTO patent grants for WAKS; Tova.The latest application filed is for "extracellular vesicles derived from activated car-t cells".

Company Profile

2.7.9

WAKS; Tova - Petach Tikva IL
WAKS; Tova - Rehovot IL
Waks; Tova - Petah Tikva IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Extracellular Vesicles Derived From Activated Car-t Cells App 20220204928 - AHARON; Anat ; et al.	2022-06-30
T-cells Comprising Two Different Chimeric Antigen Receptors And Uses Thereof App 20210300986 - ESHHAR; Zelig ; et al.	2021-09-30
T-cells Comprising Anti-cd38 And Anti-cd138 Chimeric Antigen Receptors And Uses Thereof App 20200384024 - ESHHAR; Zelig ; et al.	2020-12-10
Methods Of Culturing T Cells And Uses Of Same App 20200071669 - GEIGER; Benjamin ; et al.	2020-03-05
Immunotherapy Using Redirected Allogeneic Cells App 20170216356 - ESHHAR; Zelig ; et al.	2017-08-03
Immunotherapy using redirected allogeneic cells Grant 9,623,049 - Eshhar , et al. April 18, 2	2017-04-18
Anti-inflammatory peptides and use thereof Grant 9,346,854 - Shai , et al. May 24, 2	2016-05-24
Anti-Inflammatory Peptides And Use Thereof App 20140336105 - Shai; Yechiel ; et al.	2014-11-13
Immunotherapy Using Redirected Allogeneic Cells App 20130156794 - ESHHAR; Zelig ; et al.	2013-06-20
Chimeric receptor genes and cells transformed therewith Grant 8,211,422 - Eshhar , et al. July 3, 2	2012-07-03
Chimeric Receptor Genes And Cells Transformed Therewith App 20120093842 - Eshhar; Zelig ; et al.	2012-04-19
Chimeric receptor genes and cells transformed therewith Grant 7,741,465 - Eshhar , et al. June 22, 2	2010-06-22
Chimeric Receptor Genes And Cells Transformed Therewith App 20020137697 - ESHHAR, ZELIG A. ; et al.	2002-09-26
Endowing lymphocytes with antibody specificity Grant 5,912,172 - Eshhar , et al. June 15, 1	1999-06-15
Endowing lymphocytes with antibody specificity Grant 5,906,936 - Eshhar , et al. May 25, 1	1999-05-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.